---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-042424"
form_type: "8-K"
ticker: "RNLXY"
cik: "0001811115"
company_name: "Renalytix plc"
filed_at: "2024-04-08T23:59:59+00:00"
generated_at: "2026-06-04T01:27:50.145062+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Renalytix raises up to $4M in registered direct offering with DB Capital Partners

## Summary
- Initial tranche of $1.0M at $0.75 per ADS ($0.375 per ordinary share) closing by April 11.
- Optional second tranche of up to ~$3M at same price, exercisable until April 17.
- Net proceeds to support commercial sales activity and ongoing Formal Sale Process.
- Purchaser DB Capital Partners Healthcare will hold ~2.18% of shares after initial closing.

## SEC filing metadata
- accession: 0000950170-24-042424
- form_type: 8-K
- ticker: RNLXY
- cik: 0001811115
- company_name: Renalytix plc
- filed_at: 2024-04-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811115/000095017024042424/0000950170-24-042424-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811115/000095017024042424/rnlx-20240408.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-042424
- JSON: https://secwatch.observer/filing/0000950170-24-042424.json
- Plain text: https://secwatch.observer/filing/0000950170-24-042424.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.